MedPath

Silibinin

Generic Name
Silibinin
Drug Type
Small Molecule
Chemical Formula
C25H22O10
CAS Number
22888-70-6
Unique Ingredient Identifier
33X338MNE4
Background

Silibinin is the major active constituent of silymarin, a standardized extract of the milk thistle seeds, containing a mixture of flavonolignans consisting of silibinin, isosilibinin, silicristin, silidianin and others. Silibinin is presented as a mixture of two diastereomers, silybin A and silybin B, which are found in an approximately equimolar ratio. Both in vitro and animal research suggest that silibinin has hepatoprotective (antihepatotoxic) properties that protect liver cells against toxins. Silibinin has also demonstrated in vitro anti-cancer effects against human prostate adenocarcinoma cells, estrogen-dependent and -independent human breast carcinoma cells, human ectocervical carcinoma cells, human colon cancer cells, and both small and nonsmall human lung carcinoma cells.

Indication

Currently being tested as a treatment of severe intoxications with hepatotoxic substances, such as death cap (Amanita phalloides) poisoning.

Associated Conditions
Acute Hepatitis, Amanita Poisoning, Cirrhosis of the Liver, Clinical Deterioration of the Liver, Fatty Liver Disease, Hepatitis, Chronic, Non Alcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver, Recurrent Hepatitis, Severe alcoholic liver disease, Uncomplicated hepatic dysfunction
© Copyright 2025. All Rights Reserved by MedPath